China Merchants Securities Co., Ltd. (SHA:600999)

Lumos Pharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	153,576	161,368	108,629	107,337	143,396	185,679
Market Cap Growth	33.58%	48.55%	1.20%	-25.15%	-22.77%	64.91%
Last Close Price	18.09	18.76	13.03	12.53	15.99	20.62
PE Ratio	15.72	16.44	13.26	14.39	13.23	21.37
PS Ratio	7.21	7.74	5.52	5.63	4.89	7.66
PB Ratio	1.17	1.24	0.89	0.93	1.27	1.76
P/FCF Ratio	15.13	2.99	4.10	1.73	-	-
P/OCF Ratio	14.13	2.95	4.01	1.72	-	-
Debt / Equity Ratio	2.47	2.71	2.99	2.67	2.84	2.53
Debt / FCF Ratio	32.05	6.54	13.78	4.96	-	-
Asset Turnover	0.03	0.03	0.03	0.03	0.05	0.06
Quick Ratio	1.26	0.91	0.93	1.15	1.29	1.10
Current Ratio	1.31	1.26	1.31	1.57	1.74	1.50
Return on Equity (ROE)	8.23%	8.24%	7.39%	7.09%	10.67%	9.95%
Return on Assets (ROA)	1.62%	1.47%	1.34%	1.34%	2.13%	2.16%
Earnings Yield	6.49%	6.44%	8.07%	7.52%	8.12%	5.11%
FCF Yield	6.61%	33.44%	24.39%	57.71%	-29.02%	-5.48%
Dividend Yield	2.65%	2.55%	1.93%	1.48%	3.38%	3.74%
Payout Ratio	80.11%	85.76%	93.27%	138.46%	81.25%	81.29%
Buyback Yield / Dilution	0.32%	-	-	-	-5.89%	-3.74%
Total Shareholder Return	2.98%	2.55%	1.93%	1.48%	-2.51%	0.01%

Updated Jan 17, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.